DoubleDown Interactive DDI 深 滬
已收盤 09-05 16:00:00 美东时间
9.55
-0.090
-0.93%
華盛通- 最 高9.72
- 今 開9.72
- 成交量 3.20万股
- 最 低 9.46
- 昨 收 9.64
- 總市值 4.73亿
- 52周最高 18.214
- 市盈率 靜 3.83
- 換手率 0.06%
- 52周最低 8.09
- 委 比 -54.08%
- 總股本 4955.34万
- 歷史最高 18.50
- 量 比 0.65
- 振 幅 2.70%
- 歷史最低 6.95
- 每 手 1
- 風險率 2.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth
Syndax shares gained support after Guggenheim issued a Buy rating, citing strong Q2 results, Revuforj growth, and long-term profit potential.
09-05 03:17
eDP 接口与 LTPO OLED 面板的双驱动优化及其行业趋势
在移动智能终端不断追求高分辨率、高刷新率、高显示色深的同时，如何在丝滑、流畅的用机体验与续航之间取得平衡，已经成为移动终端厂商在显示系统优化中的核心课题。 苹果...
08-25 16:52
DoubleDown Interactive Q2 EPS $0.44 Misses $0.51 Estimate, Sales $84.813M Beat $83.183M Estimate
DoubleDown Interactive (NASDAQ:DDI) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.51 by 14.23 percent. This is a 34.33 percent decrease over earnings of $0.67 per share
08-13 04:16
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
群智咨询：预计2026年全球HV新增产能约8% 产能利用率降至约70%
8月5日，群智咨询发文称，2025年全球HV产能供应约38万片/月，投片量约29万片/月，HV产能利用率约75%。
08-05 19:39
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis Precision Medicines stock fluctuated after reporting mixed results for their drug vormatrigine in treating focal onset seizures.
08-05 01:38
强生口服多肽Icotrokinra撞线在即！
（来源：抗体圈） 在大多数人的印象中，多肽药物与口服剂型难以兼容：它们在胃肠道中易于酶解、穿膜能力弱、系统暴露不稳定。正因如此，大多数多肽药物长期依赖注射给药...
08-04 18:00
华勤技术拟约24亿元入股晶合集成，牵手晶圆代工新锐能否搅动产业链格局？
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 每经记者|朱成祥 一个是手机、笔记本、服务器代工巨头，一个是...
07-29 21:23
DoubleDown Interactive to Report 2025 Second Quarter Results on August 12 and Host Conference Call and Webcast
DoubleDown Interactive will release its 2025 second quarter financial results on August 12 after market close and host a conference call/webcast at 5:00 p.m. ET. The event, open to the public, will include a review of the Company's financial results, a business update, and a Q&A session. Registration is required in advance, with dial-in details and a unique access code provided via email. A webcast will also be available, and a replay will be pos...
07-29 11:00
服务赋能 | 热烈祝贺！抗流感新药玛硒洛沙韦片（济可舒）成功获批上市
2025年7月18日，南京征祥医药有限公司（以下简称：征祥医药）宣布自主研发的新型PA抑制剂抗流感新药济可舒（玛硒洛沙韦）正式获得中国国家药品监督管理局（NM...
07-26 01:33
